Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
The acquisition brings two commercialized, differentiated medicines—EMPAVELI and SYFOVRE —to Biogen’s growth portfolio
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
